Talking of shortages in bri’s previous post, my condition is called Ankylosing spondylitis and we have a really fantastic national association.
They recently released a list of medication that is on the at risk of low stock levels and I’m on 5 of them.
One is a biologic medication that slows my body fusing.
My fear is drugs like this that aren’t common will get dropped by NICE after brexit and I’ll have to go back to the older forms of medication which bring with it horrible side effects.
I just wondered if anyone else is thinking it’s a serious concern or a lot of fake news.